SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview newsletter visit http://www.smallcapreview.com/.
Baron Energy (OTCBB: BROE) $0.36. Today announced that it has partnered with Newport Capital Consultants, Inc. to assist the Company with market strategy and recognition.
Management Comments.
Ronnie L. Steinocher, President and CEO of Baron Energy, commented; "Newport Capital Consultants has a long and successful track record of assisting small energy companies in increasing their market presence. Having a partner like Newport Capital will enable us to accelerate our growth plans, while generating considerable institutional and public awareness." Mr. Steinocher also noted, "This partnership will allow us to adjust our plans forward for the second half of the year, including additional acquisitions and in-fill drilling programs."
What They Do: Baron Energy is an independent oil and gas production, exploitation, and exploration company headquartered in Midland, Texas with producing assets in the prolific oil producing Permian Basin of West Texas.
Baron owns production that is 99% oil, both operated and non-operated, with working interest ranging from 5% to 100% in oil and gas fields located in Baylor, Borden, Garza, Jones, Runnels, Scurry and Taylor Counties, Texas.
Baron's growth strategy centers on making accretive property acquisitions in its core operating area. The Company targets properties that have oil production with upside developmental potential.
Neoprobe Corporation (OTCBB: NEOP) $1.90. Today announced consolidated results for the first quarter of 2010. First quarter 2010 revenues were $2.7 million, consistent with the record revenue reported for the first quarter of 2009. Gross profit for the first quarter of 2010 was $1.8 million, compared to $1.9 million for the first quarter of 2009. Operating expenses increased to $3.5 million for the first quarter of 2010 from $2.1 million for the first quarter of 2009. Neoprobe’s loss from operations for the first quarter of 2010 was $1.7 million compared to $203,000 for the first quarter of 2009.
For the first quarter of 2010, Neoprobe reported a net loss attributable to common stockholders of $2.5 million, or $0.03 per share, compared to net income attributable to common stockholders of $754,000, or $0.01 per share, for the first quarter of 2009. As discussed more fully below, the first quarter 2009 net income attributable to common stockholders was primarily due to mark-to-market adjustments related to derivative accounting treatment required for certain financial instruments on the Company’s balance sheet.
What They Do: Neoprobe is a biomedical company focused on enhancing patient care and improving patient outcome by meeting the critical intraoperative diagnostic information needs of physicians and therapeutic treatment needs of patients.
MedLink (OTCBB: MLKNA) $1.05. Today announced the introduction of the newest member of its medical specialty family with the introduction of Podiatry specific modules and functionality. MedLink will begin to exhibit the Podiatry features at the New Jersey Podiatric Medical Society-Region III conference being held at the Trump Taj Mahal in Atlantic City, NJ from May 5th to May 8th.
Ray Vuono, President of MedLink stated "We've experienced significant interest recently from podiatrists in the TotalOffice EHR and we've worked closely with some industry leaders in the podiatry field to tailor modules specifically for the needs of Podiatry. Podiatry is a market segment that has largely been underserved and we're pleased to offer a robust all in one solution to meet the clinical, financial and reporting needs of Podiatric specialists. We're also excited to offer another specialty specific solution to the TotalOffice and immediate feedback from recent sales points towards the solution being well received by the podiatry market."
What They Do: MedLink is a healthcare IT company that provides the medical community with products and services designed to help create, manage, and share medical information.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com/. To follow us on Twitter visit http://twitter.com/SmallCapReview.
